Evaxion Biotech A/S
NASDAQ:EVAX

Watchlist Manager
Evaxion Biotech A/S Logo
Evaxion Biotech A/S
NASDAQ:EVAX
Watchlist
Price: 6.21 USD -3.72% Market Closed
Market Cap: 39.2m USD

Intrinsic Value

The intrinsic value of one EVAX stock under the Base Case scenario is 6.13 USD. Compared to the current market price of 6.21 USD, Evaxion Biotech A/S is Overvalued by 1%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

EVAX Intrinsic Value
6.13 USD
Overvaluation 1%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Evaxion Biotech A/S

What is Valuation History?
Ask AI Assistant
What other research platforms think about EVAX?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is EVAX valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Evaxion Biotech A/S.

Explain Valuation
Compare EVAX to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about EVAX?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Evaxion Biotech A/S

Current Assets 18.2m
Cash & Short-Term Investments 14.7m
Receivables 864k
Other Current Assets 2.6m
Non-Current Assets 4.3m
PP&E 3.6m
Other Non-Current Assets 649k
Current Liabilities 5.3m
Accounts Payable 2.5m
Other Current Liabilities 2.8m
Non-Current Liabilities 10.9m
Long-Term Debt 10.7m
Other Non-Current Liabilities 158k
Efficiency

Free Cash Flow Analysis
Evaxion Biotech A/S

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Evaxion Biotech A/S

Revenue
7.7m USD
Operating Expenses
-16.9m USD
Operating Income
-9.2m USD
Other Expenses
3.8m USD
Net Income
-5.4m USD
Fundamental Scores

EVAX Profitability Score
Profitability Due Diligence

Evaxion Biotech A/S's profitability score is 19/100. The higher the profitability score, the more profitable the company is.

ROIC is Increasing
Low 3Y Average Gross Margin
Low Gross Margin
Negative 3Y Average Net Margin
19/100
Profitability
Score

Evaxion Biotech A/S's profitability score is 19/100. The higher the profitability score, the more profitable the company is.

EVAX Solvency Score
Solvency Due Diligence

Evaxion Biotech A/S's solvency score is 35/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Negative Net Debt
Long-Term Solvency
Average D/E
35/100
Solvency
Score

Evaxion Biotech A/S's solvency score is 35/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

EVAX Price Targets Summary
Evaxion Biotech A/S

Wall Street analysts forecast EVAX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for EVAX is 12.58 USD with a low forecast of 10.1 USD and a high forecast of 16.8 USD.

Lowest
Price Target
10.1 USD
63% Upside
Average
Price Target
12.58 USD
103% Upside
Highest
Price Target
16.8 USD
171% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Evaxion Biotech A/S
does not pay dividends
Shareholder Yield

Current shareholder yield for EVAX is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one EVAX stock?

The intrinsic value of one EVAX stock under the Base Case scenario is 6.13 USD.

Is EVAX stock undervalued or overvalued?

Compared to the current market price of 6.21 USD, Evaxion Biotech A/S is Overvalued by 1%.

Back to Top